| AATZ | Z mutant of alpha-1-antitrypsin |
| AML | Acute myeloid leukemia |
| CCA | Cholangiocarcinoma |
| CIC | Cancer-initiating cell |
| CRC | Colorectal cancer |
| CSC | Cancer stem cell |
| CTD | Client-binding domain |
| EGFR | Epidermal growth factor receptor |
| EMT | Epithelial–mesenchymal transition |
| ER | Endoplasmic reticulum |
| ESCC | Esophageal squamous cell carcinoma |
| FBXO45 | F-box/SPRY domain-containing protein 1 |
| HBV | Hepatitis B virus |
| HCC | Hepatocellular carcinoma |
| HSP | Heat shock protein |
| LGMDD1 | Limb-girdle muscular dystrophy type D1 |
| MIG6 | Mitogen-inducible gene 6 |
| miRNA | MicroRNA |
| MK5 | Mitogen-activated protein kinase-activated protein kinase 5 |
| NSCLC | Non-small-cell lung carcinoma |
| PROTAC | Proteolysis-targeting chimera |
| PTM | Post-translational modification |
| sEV | Small extracellular vesicle |
| SNHG5 | Small nucleolar RNA host gene 5 |
| TCGA | The Cancer Genome Atlas |
| UPR | Unfolded protein response |